Clinical Research
Copyright ©2005 Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Nov 28, 2005; 11(44): 7001-7006
Published online Nov 28, 2005. doi: 10.3748/wjg.v11.i44.7001
Open label trial of granulocyte apheresis suggests therapeutic efficacy in chronically active steroid refractory ulcerative colitis
Wolfgang Kruis, Axel Dignass, Elisabeth Steinhagen-Thiessen, Julia Morgenstern, Joachim Mössner, Stephan Schreiber, Maurizio Vecchi, Alberto Malesci, Max Reinshagen, Robert Löfberg
Wolfgang Kruis, Julia Morgenstern, Evangelisches Krankenhaus Kalk, Innere Abteilung, Universität zu Köln, Germany
Axel Dignass, Elisabeth Steinhagen-Thiessen, Medizinische Klinik für Hepatologie und Gastroenterologie, Campus Virchow-Klinikum, Universitätsklinikum, Charité, Berlin, Germany
Joachim Mössner, Medizinische Klinik und Poliklinik II, Universitätsklinikum Leipzig, Germany
Stephan Schreiber, Medizinische Klinik, Universität Kiel, Germany
Maurizio Vecchi, Dep of Int Medicine IRCCS Ospedale Policlinico, University of Milano, Italy
Alberto Malesci, Istituto Clinico Humanitas, Milano, Italy
Max Reinshagen, Innere Medizin, Universitätsklinikum Ulm, Germany
Robert Löfberg, Karolinska Institute at the IBD unit, Sophia Hemmet, Stockholm, Sweden
Author contributions: All authors contributed equally to the work.
Correspondence to: Wolfgang Kruis, MD, Professor of Medicine, Evangelisches Krankenhaus Kalk. Buchforststr. 2, 51103 Cologne (Köln), Germany. ansorg@evkk.de
Telephone: +49-2-21-8289-5289 Fax: +49-2-21-8289-5291
Received: April 4, 2005
Revised: April 15, 2005
Accepted: April 18, 2005
Published online: November 28, 2005
Core Tip